Kyverna Therapeutics, Inc. (KYTX)

Number of records: 13
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
10-Jun-24 6:56 PM
View: 
Walker Karen Marie
Chief Technology Officer
Kyverna Therapeutics, Inc. (KYTX) 06-Jun-24Option Exercise 9,636$4.42$42,591.10100%
0 to 9.64K
29-May-24 4:33 PM
View: 
Jones Ryan Alexander
Chief Financial Officer
Kyverna Therapeutics, Inc. (KYTX) 28-May-24Option Exercise 18,016$0.73$13,151.7069%
25.93K to 43.95K
14-Feb-24 5:26 PM
View: 
Bain Capital Life Sciences ...
10% Owner
Kyverna Therapeutics, Inc. (KYTX) 12-Feb-24Conversion 2,713,870----100%
2.71M to 5.43M
14-Feb-24 7:03 PM
View: 
Cohen Fred E
Director
10% Owner
Kyverna Therapeutics, Inc. (KYTX) 12-Feb-24Conversion
Duplicate
4,523,920----100%
0 to 4.52M
13-Feb-24 5:48 PM
View: 
Gilead Sciences Inc
10% Owner
Kyverna Therapeutics, Inc. (KYTX) 12-Feb-24Purchase 910,000$22.00$20,020,000.0028%
3.22M to 4.13M
12-Feb-24 5:51 PM
View: 
Northpond Ventures III Gp, ...
Kyverna Therapeutics, Inc. (KYTX) 12-Feb-24Conversion 2,805,430----100%
0 to 2.81M
14-Feb-24 5:35 PM
View: 
Westlake Biopartners Fund I...
10% Owner
Kyverna Therapeutics, Inc. (KYTX) 12-Feb-24Conversion 4,523,920----100%
0 to 4.52M
14-Feb-24 7:04 PM
View: 
Vida Ventures, LLC
10% Owner
Kyverna Therapeutics, Inc. (KYTX) 12-Feb-24Conversion
Duplicate
4,523,920----100%
0 to 4.52M
14-Feb-24 5:26 PM
View: 
Bain Capital Life Sciences ...
10% Owner
Kyverna Therapeutics, Inc. (KYTX) 12-Feb-24Purchase
Duplicate
450,000$22.00$9,900,000.008%
5.43M to 5.88M
13-Feb-24 5:48 PM
View: 
Gilead Sciences Inc
10% Owner
Kyverna Therapeutics, Inc. (KYTX) 12-Feb-24Conversion 3,216,120----100%
0 to 3.22M
14-Feb-24 6:56 PM
View: 
Seidenberg Beth C
Director
10% Owner
Kyverna Therapeutics, Inc. (KYTX) 12-Feb-24Conversion
Duplicate
4,523,920----100%
0 to 4.52M
12-Feb-24 5:51 PM
View: 
Northpond Ventures III Gp, ...
Kyverna Therapeutics, Inc. (KYTX) 12-Feb-24Purchase 450,000$22.00$9,900,000.0016%
2.81M to 3.26M
14-Feb-24 7:04 PM
View: 
Vida Ventures, LLC
10% Owner
Kyverna Therapeutics, Inc. (KYTX) 12-Feb-24Purchase 253,136$22.00$5,568,990.006%
4.52M to 4.78M